Healthcare
Topics also related to Healthcare:
India's Emcure Pharma files for IPO
MUMBAI, July 2 - India's Emcure Pharmaceuticals Ltd, in which Blackstone Group holds a significant minority stake, has filed for an initial public offering of common stock, the company said on Tuesday.
UPDATE 1-FDA places clinical hold on Achillion's hep C drug, shares plunge
* Co says liver enzymes elevated in drug interaction with HIV drug
BRIEF-Tyco says got notices of deficiency from IRS
July 1 - July 1 - Tyco International Ltd : * Got notices of deficiency from IRS asserting several of co's former U.S. units owe additional taxes of $883.3 million plus penalties of $154 million * Says several of co's former U.S. units owe penalties of $154 million based on audits of 1997 through 2000 tax years of co. * Under 2007 tax sharing agreement,covidien;TE Connectivity would share 42%,31%,respectively,of any tax liabilities due in respect of these matters * Source
FDA places clinical hold on Achillion's hepatitis C drug
July 1 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on its hepatitis C drug sovaprevir after elevations in liver enzymes were noted in an early-stage study of the drug's interaction with an HIV drug.
Fitch Downgrades Bristol Myers Squibb's IDR to 'A-'; Outlook to Stable
(The following statement was released by the rating agency) CHICAGO, July 01 (Fitch) Fitch Ratings has downgraded Bristol-Myers Squibb Co.'s (Bristol Myers Squibb) long-term Issuer Default Rating (IDR) to 'A-' from 'A'. See a full list of affected ratings below. The ratings apply to approximately $7.3 billion of debt. The Rating Outlook is revised to Stable from Negative. KEY RATING DRIVERS --Operational pressure peaking in 2013: Plavix and Avapro patent expirations have negatively affect
| Healthcare | ||
| Johnson & Johnson | $86.63 | +0.90% |
| Pfizer Inc | $27.78 | -0.82% |
| Merck & Co Inc | $46.32 | -0.28% |
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  +48.56% |
| Basic Materials | +148.34% |
| Industrials | +65.88% |
| Cyclical Goods & Services | +67.09% |
| Non-Cyclical Goods & Services | +59.85% |
| Financials | +71.85% |
| Healthcare | +40.09% |
| Technology | +16.31% |
| Telecoms | +115.17% |
| Utilities | +68.25% |
| DOW | 14,974.96 | +65.36 |
+0.44% |
| S&P 500 | 1,614.96 | +8.68 |
+0.54% |
| NASDAQ | 3,434.49 | +31.24 |
+0.92% |
| TR US Index | 146.65 | +0.85 |
+0.58% |
-22.86Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GUOTAI JUNAN Securities Co.Ltd
|
$10.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
